Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_984e7d1c94c0922f1fa263ca86c07e29 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
filingDate |
2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9e1cb06606ecef1fd7cabe4f0bab98e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de1d5e3e93156f1f68c117c85327a72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e90be8f77bdcb2ec1bdc39d619013f29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86536645ebd790c494761aea0647f818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_294fe9058662e244de6325b34f75523d |
publicationDate |
2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9790563-B2 |
titleOfInvention |
Method for treating liver cancer |
abstract |
The invention discloses a method for evaluating therapeutic effects of lapatinib on liver cancer comprising: obtaining a liver cancer biopsy from a patient; determining level of a biomarker in the liver cancer biopsy obtained from the patient ex vivo; comparing the determined level of the biomarker in the liver cancer biopsy obtained from the patient to a reference level of the biomarker; and predicting therapeutic effect of lapatinib on liver cancer according to the comparison between the determined level and the reference level of the biomarker; wherein the reference level of the biomarker is level of the biomarker in a liver biopsy obtained from a normal, non-cancerous subject; wherein the biomarker is HBx or ErbB3. |
priorityDate |
2014-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |